Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. The company provides a broad range of products for food animals including poultry, swine, beef and dairy cattle and aquaculture. In addition to animal health and mineral nutrition products, Phibro manufactures and markets specific ingredients for use in the personal care, automotive, industrial chemical and chemical catalyst industries. Currently, Phibro focuses on regions where the majority of livestock production is consolidated in large commercial farms such as the U.S., Brazil, China, Russia, Mexico, Australia, Turkey, Israel, Canada and Europe.
| Revenue (Most Recent Fiscal Year) | $1.02B |
| Net Income (Most Recent Fiscal Year) | $2.42M |
| PE Ratio (Current Year Earnings Estimate) | 12.10 |
| PE Ratio (Trailing 12 Months) | 12.78 |
| PEG Ratio (Long Term Growth Estimate) | 0.47 |
| Price to Sales Ratio (Trailing 12 Months) | 0.84 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 3.76 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 11.67 |
| Pre-Tax Margin (Trailing 12 Months) | 4.25% |
| Net Margin (Trailing 12 Months) | 2.68% |
| Return on Equity (Trailing 12 Months) | 30.51% |
| Return on Assets (Trailing 12 Months) | 6.89% |
| Current Ratio (Most Recent Fiscal Quarter) | 2.91 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.23 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 2.67 |
| Inventory Turnover (Trailing 12 Months) | 2.30 |
| Book Value per Share (Most Recent Fiscal Quarter) | $6.56 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.63 |
| Earnings per Share (Most Recent Fiscal Year) | $1.19 |
| Diluted Earnings per Share (Trailing 12 Months) | $0.78 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Common Shares Outstanding | 40.53M |
| Free Float | 20.24M |
| Market Capitalization | $999.56M |
| Average Volume (Last 20 Days) | 0.28M |
| Beta (Past 60 Months) | 0.62 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 50.07% |
| Percentage Held By Institutions (Latest 13F Reports) | 99.34% |
| Annual Dividend (Based on Last Quarter) | $0.48 |
| Dividend Yield (Based on Last Quarter) | 1.95% |